EGFR and interstitial lung disease: ECOG > 2 [16], pre-existing interstitial lung disease (ILD) [16,20,21,22], squamous cell histology [20], combination therapies of ICI [20] and EGFR TKIs [23,24] are discussed as potential risk factors for CIP.